Literature DB >> 8432432

The toxicologic and oncogenic potential of JP-4 jet fuel vapors in rats and mice: 12-month intermittent inhalation exposures.

R H Bruner1, E R Kinkead, T P O'Neill, C D Flemming, D R Mattie, C A Russell, H G Wall.   

Abstract

Three-hundred Fischer 344 rats and 300 C57BL/6 mice of each sex were divided into three treatment groups and exposed intermittently (6 hr/day, 5 days/week) to JP-4 jet fuel vapors at concentrations of 0, 1000, and 5000 mg/m3 for 12 months. At exposure termination, 10% of the animals were killed and those remaining were held for a 12-month postexposure tumorigenesis observation period. Pathologic findings in male rats revealed treatment-related renal toxicity and neoplasia consistent with the male rat unique alpha 2 mu-globulin nephropathy syndrome. Distinct JP-4-induced respiratory toxicity was not observed, and pulmonary neoplasms were not significantly increased in any treatment group. Benign hepatocellular adenomas were slightly increased in high-dose female mice, but the trend was reversed in male mice. Other pathologic findings were regarded as equivocal or compatible with expected biologic variation. The study did not demonstrate target organ toxicity or carcinogenesis which could be extrapolated to other species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432432     DOI: 10.1006/faat.1993.1012

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  2 in total

Review 1.  A proposed approach to study the toxicology of complex mixtures of petroleum products: the integrated use of QSAR, lumping analysis and PBPK/PD modeling.

Authors:  H J Verhaar; J R Morroni; K F Reardon; S M Hays; D P Gaver; R L Carpenter; R S Yang
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

Review 2.  Alpha 2u-globulin nephropathy: review of the cellular and molecular mechanisms involved and their implications for human risk assessment.

Authors:  J A Swenberg
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.